GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Float Percentage Of Total Shares Outstanding

Voyageur Pharmaceuticals (TSXV:VM) Float Percentage Of Total Shares Outstanding : 0.00% (As of Apr. 30, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Voyageur Pharmaceuticals's float shares is 0.00 Mil. Voyageur Pharmaceuticals's total shares outstanding is 160.43 Mil. Voyageur Pharmaceuticals's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Voyageur Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Voyageur Pharmaceuticals's Institutional Ownership is 0.00%.


Voyageur Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Voyageur Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/160.43
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Voyageur Pharmaceuticals Business Description

Industry
Traded in Other Exchanges
Address
4103B Center Street NW, Calgary, AB, CAN, T2E 2Y6
Voyageur Pharmaceuticals Ltd is engaged in acquiring, exploring, and developing raw materials for pharmaceutical products. The company's products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD, and V-Gas.
Executives
Bradley Craig Willis Director, Senior Officer
Trent Abraham Director
Charles Littlejohn 10% Security Holder

Voyageur Pharmaceuticals Headlines

No Headlines